1.
Am J Hematol
; 96(10): E390-E392, 2021 10 01.
Article
in English
| MEDLINE
| ID: mdl-34260089
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Epstein-Barr Virus Infections/complications , Plasmablastic Lymphoma/drug therapy , Plasmablastic Lymphoma/radiotherapy , Aged , HIV Infections/complications , Herpesvirus 4, Human/isolation & purification , Humans , Male , Plasmablastic Lymphoma/complications , Treatment Outcome
2.
JNMA J Nepal Med Assoc
; 56(206): 271-273, 2017.
Article
in English
| MEDLINE
| ID: mdl-28746329
ABSTRACT
Plasmablastic lymphoma is a rare and aggressive lymphoma reported to be commonly associated with immunodeficiency state. It possesses a challenge to the clinician owing it aggressiveness and poor prognosis. No standard of care treatment is available for the disease. Here we report a case of an immunocompetant 67 years female who is unique in her presentation as she did not have any of the conventional clinical features and had a history of urothelial carcinoma three months back.